Effects of mtor-is on malignancy and survival following renal transplantation: a systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months

HIGHLIGHTS

• who: Sebastian Wolf et al. from the Department of General, Visceral and Transplant Surgery, Ludwig-Maximilian's University, Munich, University, Munich, Germany have published the Article: Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0194975]. April 16, 2018 of October/30,/2017
• what: For this trial, only de novo mTOR-I use was included and no difference was made between the patients receiving . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.